Click on the icons for more information about each of our big picture challenges. Alternatively, choose from the four categories below.

Achieving better integration between health, social care and support organisations Shifting the focus of the system towards prevention and well-being Delivering the personalisation agenda and providing person-centred care within financial constraints Ensuring the system delivers high-quality services within financial constraints Collecting high quality data to effectively measure quality of care and productivity Preparing for changes resulting from innovation and technology Planning service delivery given the uncertainty about level of funding in the future Uncertainty about how investment in life science, health and care will support the UK economy

Uncertainty about how investment in life science, health and care will support the UK economy

HITS 243
LINKED DRIVERS 0

Description

The UK currently has one of the world’s strongest and most productive life science economies. In 2009, £4.4 billion was spent on pharmaceutical research and development in the UK. Medical technology and biotechnology sectors also had an annual turnover of around £18.4 billion. The Government has put measures in place to ensure that the UK remains a globally competitive environment (UK Trade and Investment, 2012). It is currently unclear how this investment in science and technology will impact on treating long-term conditions. If these investments are able to support people with long-term conditions to stay healthier for longer, there may be significant impacts on the number and types of health and care services required for the future.


Some of the information in this section is provided by stakeholders and expert groups, and does not necessarily represent the views of the CfWI.

Contact Accessibility Terms and conditions Privacy
Powered by